{"id":"https://openalex.org/W7225006147","doi":"https://doi.org/10.1021/acs.jmedchem.6c01364","title":"Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGF\u03b2-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity","display_name":"Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGF\u03b2-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity","publication_year":2026,"publication_date":"2026-10-31","ids":{"openalex":"https://openalex.org/W7225006147","doi":"https://doi.org/10.1021/acs.jmedchem.6c01364"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.6c01364","doi":"https://doi.org/10.1021/acs.jmedchem.6c01364","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6c01364","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101053998","display_name":"Yingying Zuo","orcid":"https://orcid.org/0009-0008-2556-8387","observed_orcids":["https://orcid.org/0009-0008-2556-8387"]},"institutions":[{"id":"https://openalex.org/I20231570","display_name":"Peking University","ror":"https://ror.org/02v51f717","country_code":"CN","type":"education","lineage":["https://openalex.org/I20231570"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yingying Zuo","raw_affiliation_strings":["Peking University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peking University , , ,","institution_ids":["https://openalex.org/I20231570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015231337","display_name":"Tiancheng Fu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I20231570","display_name":"Peking University","ror":"https://ror.org/02v51f717","country_code":"CN","type":"education","lineage":["https://openalex.org/I20231570"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tiancheng Fu","raw_affiliation_strings":["Peking University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peking University , , ,","institution_ids":["https://openalex.org/I20231570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109602430","display_name":"Xuan Chen","orcid":"https://orcid.org/0009-0007-3605-4018","observed_orcids":["https://orcid.org/0009-0007-3605-4018"]},"institutions":[{"id":"https://openalex.org/I20231570","display_name":"Peking University","ror":"https://ror.org/02v51f717","country_code":"CN","type":"education","lineage":["https://openalex.org/I20231570"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xuan Chen","raw_affiliation_strings":["Peking University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peking University , , ,","institution_ids":["https://openalex.org/I20231570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111483713","display_name":"Fengli He","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I20231570","display_name":"Peking University","ror":"https://ror.org/02v51f717","country_code":"CN","type":"education","lineage":["https://openalex.org/I20231570"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fengli He","raw_affiliation_strings":["Peking University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peking University , , ,","institution_ids":["https://openalex.org/I20231570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160265087","display_name":"Xingwei Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I20231570","display_name":"Peking University","ror":"https://ror.org/02v51f717","country_code":"CN","type":"education","lineage":["https://openalex.org/I20231570"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xingwei Chen","raw_affiliation_strings":["Peking University , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peking University , , ,","institution_ids":["https://openalex.org/I20231570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077398318","display_name":"Lars Wortmann","orcid":"https://orcid.org/0000-0001-6514-947X","observed_orcids":["https://orcid.org/0000-0001-6514-947X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Lars Wortmann","raw_affiliation_strings":["Bayer AG , , Muellerstrasse 178 , ,"],"raw_orcid":"https://orcid.org/0000-0001-6514-947X","affiliations":[{"raw_affiliation_string":"Bayer AG , , Muellerstrasse 178 , ,","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103032170","display_name":"Volker Schulze","orcid":"https://orcid.org/0000-0002-0158-1789","observed_orcids":["https://orcid.org/0000-0002-0158-1789"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Volker K. Schulze","raw_affiliation_strings":["Bayer AG , , Muellerstrasse 178 , ,"],"raw_orcid":"https://orcid.org/0000-0002-0158-1789","affiliations":[{"raw_affiliation_string":"Bayer AG , , Muellerstrasse 178 , ,","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160251388","display_name":"Tobias Kerst Heinrich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tobias Kerst Heinrich","raw_affiliation_strings":["Bayer AG , , Muellerstrasse 178 , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , Muellerstrasse 178 , ,","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091589487","display_name":"Detlev Suelzle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Detlev Suelzle","raw_affiliation_strings":["Bayer AG , , Muellerstrasse 178 , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG , , Muellerstrasse 178 , ,","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044740532","display_name":"Franz von Nussbaum","orcid":"https://orcid.org/0000-0001-7188-7364","observed_orcids":["https://orcid.org/0000-0001-7188-7364"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Franz v. Nussbaum","raw_affiliation_strings":["Bayer AG , , Muellerstrasse 178 , ,"],"raw_orcid":"https://orcid.org/0000-0001-7188-7364","affiliations":[{"raw_affiliation_string":"Bayer AG , , Muellerstrasse 178 , ,","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057020520","display_name":"Zhengying Pan","orcid":"https://orcid.org/0000-0002-4312-7103","observed_orcids":["https://orcid.org/0000-0002-4312-7103"]},"institutions":[{"id":"https://openalex.org/I20231570","display_name":"Peking University","ror":"https://ror.org/02v51f717","country_code":"CN","type":"education","lineage":["https://openalex.org/I20231570"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Zhengying Pan","raw_affiliation_strings":["Peking University , , ,"],"raw_orcid":"https://orcid.org/0000-0002-4312-7103","affiliations":[{"raw_affiliation_string":"Peking University , , ,","institution_ids":["https://openalex.org/I20231570"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5057020520"],"corresponding_institution_ids":["https://openalex.org/I20231570"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.72613246,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.5853999853134155,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.5853999853134155,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.15629999339580536,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.13750000298023224,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tak1","display_name":"TAK1","score":0.8399999737739563},{"id":"https://openalex.org/keywords/alpha-beta-unsaturated-aldehydes","display_name":"\u03b1,\u03b2-unsaturated aldehydes","score":0.949999988079071},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8339999914169312},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.7020000219345093},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.5989999771118164},{"id":"https://openalex.org/keywords/tak1-signaling","display_name":"TAK1 signaling","score":0.5649999976158142}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8615999817848206},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7705000042915344},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6600000262260437},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4731000065803528},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4244000017642975},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.4174000024795532},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.39730000495910645},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.39079999923706055},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.39010000228881836},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.38269999623298645},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3677000105381012},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.366100013256073},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.33820000290870667},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.31790000200271606},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30730000138282776},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.29679998755455017},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.2906000018119812},{"id":"https://openalex.org/C132149769","wikidata":"https://www.wikidata.org/wiki/Q899651","display_name":"Mitogen-activated protein kinase","level":3,"score":0.28189998865127563},{"id":"https://openalex.org/C2777752112","wikidata":"https://www.wikidata.org/wiki/Q903238","display_name":"Lead compound","level":3,"score":0.2718999981880188},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2565999925136566}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/acs.jmedchem.6c01364","doi":"https://doi.org/10.1021/acs.jmedchem.6c01364","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6c01364","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307771","display_name":"Bayer","ror":"https://ror.org/04hmn8g73"},{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320324787","display_name":"Peking University","ror":"https://ror.org/02v51f717"},{"id":"https://openalex.org/F4320337111","display_name":"Basic and Applied Basic Research Foundation of Guangdong Province","ror":null}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1964176593","https://openalex.org/W1975523550","https://openalex.org/W1980415233","https://openalex.org/W2005792688","https://openalex.org/W2030882382","https://openalex.org/W2031061765","https://openalex.org/W2038331455","https://openalex.org/W2039688872","https://openalex.org/W2053624316","https://openalex.org/W2059421466","https://openalex.org/W2064439294","https://openalex.org/W2077515371","https://openalex.org/W2079188851","https://openalex.org/W2083526450","https://openalex.org/W2089463924","https://openalex.org/W2097491315","https://openalex.org/W2102080841","https://openalex.org/W2117022661","https://openalex.org/W2122873183","https://openalex.org/W2151457918","https://openalex.org/W2155868854","https://openalex.org/W2293555343","https://openalex.org/W2419408332","https://openalex.org/W2467476999","https://openalex.org/W2560850808","https://openalex.org/W2566007857","https://openalex.org/W2749127222","https://openalex.org/W2765567550","https://openalex.org/W2803985368","https://openalex.org/W2901549732","https://openalex.org/W2905441583","https://openalex.org/W3015980639","https://openalex.org/W3093890067","https://openalex.org/W3133856646","https://openalex.org/W4214904315","https://openalex.org/W4380290698","https://openalex.org/W4389104274","https://openalex.org/W4404626927","https://openalex.org/W4407099358"],"related_works":["https://openalex.org/W2403057159","https://openalex.org/W2330658471","https://openalex.org/W2905441583","https://openalex.org/W2560850808","https://openalex.org/W2074407062","https://openalex.org/W2021041611","https://openalex.org/W2904214782","https://openalex.org/W4407099358","https://openalex.org/W3093890067","https://openalex.org/W4308460782"],"abstract_inverted_index":{"Abstract":[0],"TGF\u03b2-activated":[1],"kinase":[2],"1":[3],"(TAK1)":[4],"plays":[5],"essential":[6],"roles":[7],"in":[8,18,45,76,85,93],"proinflammatory":[9],"and":[10,14,24,44,78,130],"prosurvival":[11],"signaling":[12,75],"pathways,":[13],"has":[15],"been":[16,31],"implicated":[17],"various":[19],"human":[20],"diseases,":[21],"including":[22],"cancer":[23],"inflammation.":[25],"Although":[26,100],"several":[27],"TAK1":[28,63,82,128],"inhibitors":[29],"have":[30],"reported,":[32],"an":[33],"effective":[34],"tool":[35],"compound":[36,68,117],"with":[37],"a":[38,54,61,80,94,101,120],"combination":[39],"of":[40,106,127,136],"favorable":[41],"potency,":[42],"selectivity,":[43],"vivo":[46],"efficacy":[47],"is":[48],"still":[49],"lacking.":[50],"Herein,":[51],"we":[52],"present":[53],"7-aminofuro[2,3-c]pyridine-based":[55],"\u03b1,\u03b2-unsaturated":[56],"aldehyde":[57],"(compound":[58],"26)":[59],"as":[60],"potent":[62],"irreversible":[64],"covalent":[65],"inhibitor.":[66],"This":[67],"exhibited":[69],"excellent":[70],"inhibitory":[71],"activity":[72],"for":[73,124],"TAK1-dependent":[74],"cells":[77],"demonstrated":[79],"sustained":[81],"inhibition":[83,105],"effect":[84],"vivo.":[86],"Furthermore,":[87],"it":[88],"significantly":[89],"prevented":[90],"tumor":[91],"growth":[92],"lymphoma":[95],"(DoHH2)":[96],"xenograft":[97],"mouse":[98],"model.":[99],"contribution":[102],"from":[103],"the":[104,110,134],"other":[107],"kinases":[108],"to":[109],"observed":[111],"effects":[112],"cannot":[113],"be":[114],"ruled":[115],"out,":[116],"26":[118],"provides":[119],"promising":[121],"starting":[122],"point":[123],"further":[125],"optimization":[126],"selectivity":[129],"pharmacokinetic":[131],"properties":[132],"toward":[133],"development":[135],"TAK1-targeted":[137],"agents.":[138]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-11-01T00:00:00"}